パーキンソン病の概要:ナラティブ・レビュー
Hiba Shamweel1, Shamweel Ahmad2
1Research Scholar, Faculty of Medicine and Health Sciences, Universiti Putra Malaysia, Serdang, Malaysia.
Informatics for health & social care
|February 16, 2026
まとめ
パーキンソン病 (PD) の管理は,物理療法やAIのような新興技術により,診断と治療を向上させ,進化しています. このレビューでは,PD,その危険因子,および患者のアウトカムを改善するための革新的なリハビリテーション戦略を調査します.
科学分野:
- 神経学 神経学とは
- リハビリテーション・サイエンス・サイエンス
背景:
- パーキンソン病 (PD) は,運動および非運動症状を特徴とする神経変性疾患です.
- 姿勢不安定 (PI) は,PDの重要な症状であり,患者の障害や生活の質に大きな影響を与えます.
研究 の 目的:
- 病理生理学,診断,危険因子,管理戦略を含むPDの現在の理解をレビューする.
- 理学療法,デジタルヘルス,人工知能 (AI) に焦点を当てて,PDケアにおける進歩を強調する.
主な方法:
- パーキンソン病に関する利用可能な研究の文献レビュー.
- 診断基準,危険因子,治療方法 (薬理学的および非薬理学的) の分析.
主要な成果:
- PDの診断は,臨床的評価,運動の変動,ドーパミナージック療法への反応に依存しています.
- 物理療法は,PDの症状管理の礎石です.
- デジタルヘルスケア技術とAIは,PD診断と患者のアウトカムを改善する見込みを示しています.
結論:
- PDの効果的な管理には,薬理学的および非薬理学的介入を組み合わせた多面的なアプローチが必要です.
- 新興技術は,PDのケアを変革し,診断,治療,リハビリテーションの新たな機会を提供しています.
- 革新的なツールとAIに関するさらなる研究は,PD患者のアウトカムを前進させるために不可欠です.
関連する概念動画
Parkinson's Disease: Overview
2.1K
Neurodegenerative disorders are progressive diseases that cause irreversible damage and loss to neurons in specific brain areas. Examples of these disorders include Parkinson's disease, Alzheimer's disease, Multiple Sclerosis (MS), and Amyotrophic Lateral Sclerosis (ALS). These disorders share characteristics such as proteinopathies, selective neuronal vulnerability, and a complex interplay between genetic and environmental factors. The primary therapeutic goal for these conditions is...
2.1K
Parkinson's Disease: Treatment
1.2K
Neurodegenerative disorders, such as Parkinson's Disease (PD), involve the gradual and irreversible destruction of neurons in particular brain areas. These disorders exhibit standard features like proteinopathies, selective vulnerability of some neurons, and an interaction of intrinsic properties, genetics, and environmental influences in neural injury.
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of...
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of...
1.2K
Neural Regulation
43.5K
Digestion begins with a cephalic phase that prepares the digestive system to receive food. When our brain processes visual or olfactory information about food, it triggers impulses in the cranial nerves innervating the salivary glands and stomach to prepare for food.
43.5K
Alzheimer's Disease: Overview
1.8K
Alzheimer's Disease (AD) is a continually advancing neurodegenerative disorder, distinguished by escalating memory loss, cognitive dysfunction, and dementia. The disease unfolds in three stages: preclinical, mild cognitive impairment (MCI), and dementia. Its onset is insidious, and the progression gradual, with the cause not well explained by other disorders.
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
1.8K
Lysosomal Hydrolases
4.6K
Lysosomes are the site for the degradation of macromolecules and biological polymers released during membrane trafficking events such as secretory, endocytic, autophagic, and phagocytic pathways. The membrane-enclosed area of the lysosome, called the lumen, contains hydrolytic enzymes active in an acidic environment. These acid hydrolases are functional at a pH between 4.5 and 5 and are involved in cellular processes such as cell signaling, energy metabolism, restoration of the plasma membrane,...
4.6K
Psychosis and Antipsychotic Drugs: Overview
943
The term "psychosis" refers to a spectrum of mental disorders characterized by abnormal thoughts, perceptions, and behaviors. It can manifest as mood disorders, dementia, delirium with psychotic features, substance-induced psychosis with psychotic features, brief psychotic disorder, delusional disorder, schizoaffective disorder, and schizophrenia. Among all these disorders, schizophrenia is the most common psychotic disorder, affecting 1% of the worldwide population. Psychotic...
943


